Friday, August 21, 2009

Now Here's Something Totally Romantic


When we think of the way that viruses get transmitted, we automatically think of the cough or the sneeze. But wait: what about that welcoming kiss when the wife returns from a hard day at the office.
Check out what the CDC is recommending:
CDC to College Students: Smooch With Surgical Masks to Curb Swine Flu

The opening of the fall semester is always a time of newfound relationships. Advise your customers to stock up on high quality surgical masks!!.

Weirdest Drug Information Request I've Ever Seen

I've been a Drug Information Pharmacist for longer that I'd like to admit. I have fielded some really weird questions over the years, but this one takes the cake (so to speak). WARNING. before you open this file I want to advise you that it is a little crude, rude, and obnoxious. Maybe you will get this question sometime in your future practice:

http://answers.yahoo.com/question/index?qid=20090806224752AABPMoW

Now, if the medication was Altoids I might find it more feasible!!

CASPPER, GlaxoSmithKline’s Friendly Ghostwriting Program





A while back I posted an item about scientific articles being "ghostwritten" by professional outfits, hired by pharmaceutical companies to author scientific articles, after which the names of well-known scientists and researchers are substituted or added as authors. Well, the issue is really heating up now.


The Chicago Tribune published an article on August 20, 2009, talking about a program called CASPPER. Funded by GlaxoSmithKline, many of the articles focus on the antidepressant drug, Paxil. Here is a link to that story.


http://www.chicagotribune.com/business/sns-ap-us-glaxosmithkline-ghostwriting,0,4281174.story


The Wall Street Journal is also in the fray:


http://blogs.wsj.com/health/2009/08/20/caspper-glaxosmithklines-friendly-ghostwriting-program/


Yesterday, The New York Times posted a similar article detailing how another company used ghostwriters to prepare scientific papers for publications in major medical journals. Check out this article:


http://www.nytimes.com/2009/08/19/health/research/19ethics.html


In academia, we would probably call this plagiarism and haul any offenders before the Student Conduct Committee. Look for more on this subject.

Friday, August 7, 2009

Roll Your Own. Our Pharmacists Can't Roll Them for You.


Such says the small sign plastered on my office wall.
When I first saw this sign in a curio shop in Fernandina Beach, I said to myself, "I gotta have that."

Why, you ask? The mere thought of pharmacists dispensing krippie or some other grade of marijuana makes my skin crawl. Yes, we are all accustomed to patients asking to buy some type of herb, but I don't this this is the herb they are talking about.

Journalist Anderson Cooper of CNN recently did a series on medical marijuana in California. Take a look at one of your pharmacy counterparts as she demonstrates her expertise about this special kind of herbal medicine. Personally, it really bums me out. (Is that expression still used?)



Thursday, August 6, 2009

The Origin of the Phrase "The Power's in Your Heart, Sir"

So, what's the real meaning of this phrase "The Power's in Your Heart, Sir? Well, it's a really long story, but Iwill try to keep it short.

On Halloween Day, 2008, the self-care case was about foot problems. I decided to dress up in a costume and portray a patient with a n ingrown toenail. What happens next can only be understood by watching the short video.

It seems that , for some strage reason, fridays seem to be a little wild. That's why they call it "Frisky Friday"

Marijuana Lozenges for Swine Flu? I don't think so!


Being a pharmacist for over 35 years, I thought I had seen everything. Lately I have come to realize that people will come up with the craziest ideas to treat diseases or get high.

Robert Melamede and his company, Cannabis Science, hope to one day make marijuana available nationwide to kids and teens -- as well as adults -- in the form of a medicinal throat lozenge. He believes it can curb the death risk from swine flu. He hypothesizes that the chemicals in marijuana known as cannabinoids have a dampening effect on the immune system.

Don't look for these on the shelf just yet (or ever, I hope). My advice would be to stick to Smith Brothers Wild Cherry Cough Drops. Then you won't have to worry about flunking a drug test.

Wednesday, August 5, 2009

"I Thought I Saw a G-G-G-Ghost!"


One of the steps in evaluating any research paper is to determine whether the author(s) are well-positioned to do the research. Typically, what one does is run a PubMed search to see how many articles they have published and where they have published them.

It is becoming increasingly clear that not all papers are actually written by the person whose name appears on the article. Instead, pharmaceutical companies commission professional writers to "draft" the article and when it is submitted for publication, some well known author's name suddenly appears on the article.

As part of some recent legal proceedings, these "ghostwritten" articles have come to light. The link below will take you to a New York Times articletalking about these modern day Ghostbusters.

Monday, August 3, 2009

When a Side-Effect Turns Out to Be a Goldmine


Can you recall the FDA defintion of a side effect? I can't recite the precise defintion, but I know it goes something like this: "Any unwanted, unintended, noxious effect of a drug when given in typical therapeutic doses." Howver, a side-effect can only be defnined in the context of its desired effect. Further, the side-effect may have much more market potnetioal thant the"regular" effect. Considet he example below.

Quoting from New York Times aticle: "Latisse is a recent example of just that. Like Botox (and like a number of other prescription drugs, including Viagra), Latisse came about indirectly. During clinical testing of a glaucoma medication called Lumigan, Allergan’s researchers noted a side effect: eyelash growth. Recognizing the market potential for such a thing, the company conducted a new safety-and-efficacy study, this time making the former side effect the main focus, explained Robert Grant, the president of Allergan Medical, the company’s aesthetic-products division. In December, the Food and Drug Admionistration gave Allergan clearance for this new use. By May, Latisse ads were on the air, and in its first three months on the market, the product totaled about $12 million in sales. That’s nothing compared with Botox, which has annual sales that exceed half a billion dollars for cosmetic use,but it does suggest that there is a bigger market for eyelash-hypotrichosis relief than you might have guessed before Latisse’s promotional campaign began.


To read the whole article click on this link: